The effectiveness of expanded carrier screening based on next-generation sequencing for severe monogenic genetic diseases
Abstract Expanded carrier screening (ECS) based on next-generation sequencing has been the subject of few studies to estimate the effectiveness of ECS in the Chinese population. A total of 3737 individuals from Southwest China or the general Chinese population, including 1048 pairs and 1641 individuals, were analysed by ECS for 155 monogenetic diseases. An ECS panel was used to detect 147 genes and 10,449 variants in 145 autosomal recessive and 10 X-linked recessive disorders. A total of 43.27% (1617/3737) were found to be carriers of at least one of the 155 monogenetic diseases. The average number of carriers of these recessive mutations was 0.54 and ranged from 0 to 4. Of the 1048 couples, 74.81% (n = 784) were found to have at least one partner carrying more than one disease. In addition, 5.34% of the couples at risk (n = 56) were heterozygous for the same autosomal recessive disease, and 0.37% of the women (9/2440) were carriers of X-linked diseases. Our study demonstrated the clinical significance of ECS in Chinese populations and the need for a programme of familial screening for the prevention of severe recessive monogenetic diseases..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Human Genomics - 18(2024), 1, Seite 8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xue Zhang [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Expanded screening carrier |
---|
doi: |
10.1186/s40246-024-00577-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ09117709X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ09117709X | ||
003 | DE-627 | ||
005 | 20240414051542.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240412s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s40246-024-00577-w |2 doi | |
035 | |a (DE-627)DOAJ09117709X | ||
035 | |a (DE-599)DOAJb0d2517d29ce432a9eb752804cc51abf | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QH426-470 | |
100 | 0 | |a Xue Zhang |e verfasserin |4 aut | |
245 | 1 | 4 | |a The effectiveness of expanded carrier screening based on next-generation sequencing for severe monogenic genetic diseases |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Expanded carrier screening (ECS) based on next-generation sequencing has been the subject of few studies to estimate the effectiveness of ECS in the Chinese population. A total of 3737 individuals from Southwest China or the general Chinese population, including 1048 pairs and 1641 individuals, were analysed by ECS for 155 monogenetic diseases. An ECS panel was used to detect 147 genes and 10,449 variants in 145 autosomal recessive and 10 X-linked recessive disorders. A total of 43.27% (1617/3737) were found to be carriers of at least one of the 155 monogenetic diseases. The average number of carriers of these recessive mutations was 0.54 and ranged from 0 to 4. Of the 1048 couples, 74.81% (n = 784) were found to have at least one partner carrying more than one disease. In addition, 5.34% of the couples at risk (n = 56) were heterozygous for the same autosomal recessive disease, and 0.37% of the women (9/2440) were carriers of X-linked diseases. Our study demonstrated the clinical significance of ECS in Chinese populations and the need for a programme of familial screening for the prevention of severe recessive monogenetic diseases. | ||
650 | 4 | |a Expanded screening carrier | |
650 | 4 | |a Next-generation sequencing | |
650 | 4 | |a Monogenic genetic diseases | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Genetics | |
700 | 0 | |a Qian Chen |e verfasserin |4 aut | |
700 | 0 | |a Junnan Li |e verfasserin |4 aut | |
700 | 0 | |a Xin Luo |e verfasserin |4 aut | |
700 | 0 | |a Jianyun Luo |e verfasserin |4 aut | |
700 | 0 | |a Jian Li |e verfasserin |4 aut | |
700 | 0 | |a Ziye Zeng |e verfasserin |4 aut | |
700 | 0 | |a Yan Wu |e verfasserin |4 aut | |
700 | 0 | |a Hua Zhang |e verfasserin |4 aut | |
700 | 0 | |a Yanling Dong |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Human Genomics |d BMC, 2012 |g 18(2024), 1, Seite 8 |w (DE-627)DOAJ000133515 |x 14797364 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2024 |g number:1 |g pages:8 |
856 | 4 | 0 | |u https://doi.org/10.1186/s40246-024-00577-w |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/b0d2517d29ce432a9eb752804cc51abf |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1186/s40246-024-00577-w |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1479-7364 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 18 |j 2024 |e 1 |h 8 |